Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation is a research paper published in eLife (2024). On theSindex it has a DataRank of 0.456. It has been cited 9 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.111
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
Cancer Prevention and Research Institute of Texas
Grant: R1219
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK110361
Cancer Prevention and Research Institute of Texas
Grant: RP170345
National Cancer Institute of the United States
Grant: ZIA BC011798
William and Ella Owens Medical Research Foundation, and National Cancer Institute
Grant: R21 CA218968
William and Ella Owens Medical Research Foundation, and National Cancer Institute
Grant: R01 CA237159
CPRIT Research Training
Grant: RP140105
NCI NIH HHS
Grant: P30 CA054174
National Institutes of Health
Grant: 5R21CA218968-02
Novel model to study PDAC using normal human pancreatic tissue
National Institutes of Health
Grant: 5R01DK110361-05
The Hippo signaling pathway in pancreatic epithelial cells orchestrate the inflammatory response R01
National Institutes of Health
Grant: 5R01CA237159-06
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
Fields of Study
MeSH Terms
Keywords